Patients undergoing cataract surgery treated with a nepafenac punctal plug delivery system experienced significantly less postoperative pain compared with those treated with a placebo punctal plug, according to a study.
“The most important finding of the trial is the nepafenac Evolute patients had a significantly higher percentage of pain-free patients than the placebo group. This included 52% of patients in the nepafenac group who were pain-free at all post-surgical visits vs. 0% in the placebo group,” study co-author and OSN Cornea/External Disease Board Member Eric D.
Uncategorized